Abstract:Radiation fibrosis of the lung is a late toxicity of thoracic irradiation. Epidermal growth factor (EGF) signaling has previously been implicated in radiation lung injury. We hypothesized that TGF-α, an EGF receptor ligand, plays a key role in radiation-induced fibrosis in lung. Mice deficient in transforming growth factor (TGF-α(-/-)) and control C57Bl/6J (C57-WT) mice were exposed to thoracic irradiation in 5 daily fractions of 6 Gy. Cohorts of mice were followed for survival (n ≥ 5 per group) and tissue collection (n = 3 per strain and time point). Collagen accumulation in irradiated lungs was assessed by Masson's trichrome staining and analysis of hydroxyproline content. Cytokine levels in lung tissue were assessed with ELISA. The effects of TGF-α on pneumocyte and fibroblast proliferation and collagen production were analyzed in vitro. Lysyl oxidase (LOX) expression and activity were measured in vitro and in vivo. Irradiated C57-WT mice had a median survival of 24.4 weeks compared to 48.2 weeks for irradiated TGF-α(-/-) mice (P = 0.001). At 20 weeks after irradiation, hydroxyproline content was markedly increased in C57-WT mice exposed to radiation compared to TGF-α(-/-) mice exposed to radiation or unirradiated C57-WT mice (63.0, 30.5 and 37.6 μg/lung, respectively, P = 0.01). C57-WT mice exposed to radiation had dense foci of subpleural fibrosis at 20 weeks after exposure, whereas the lungs of irradiated TGF-α (-/-) mice were largely devoid of fibrotic foci. Lung tissue concentrations of IL-1β, IL-4, TNF-α, TGF-β and EGF at multiple time points after irradiation were similar in C57-WT and TGF-α(-/-) mice. TGF-α in lung tissue of C57-WT mice rose rapidly after irradiation and remained elevated through 20 weeks. TGF-α(-/-) mice had lower basal LOX expression than C57-WT mice. Both LOX expression and LOX activity were increased after irradiation in all mice but to a lesser degree in TGF-α(-/-) mice. Treatment of NIH-3T3 fibroblasts with TGF-α resulted in increases in proliferation, collagen production and LOX activity. These studies identify TGF-α as a critical mediator of radiation-induced lung injury and a novel therapeutic target in this setting. Further, these data implicate TGF-α as a mediator of collagen maturation through a TGF-β independent activation of lysyl oxidase.

Transformation growth factor-β1 and radiation-induced fibrosis of the jaw bone

[Crosstalk Between Canonical TGF-β/Smad and Wnt/β-catenin Signaling Pathway].

Transforming Growth Factor-Β1/smad/connective Tissue Growth Factor Axis: the Main Pathway in Radiation-Induced Fibrosis of Osteoradionecrosis?

Transforming Growth Factor Β Signaling and Odontoblast Differentiation

[Review on Transforming Growth Factor Beta and Repair of Tissue Injury].

Transforming Growth Factor-β1 to the Bone

Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts

Transforming growth factor-beta1 to the bone.

Targeting TGF-β signal transduction for fibrosis and cancer therapy

The mechanism of profibrotic effect of connective tissue growth factor

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities

TGF-β1 induced miR-21 overexpression regulates myofibroblast differentiation of rat mesenchymal stem cells and contributes to radiation-induced fibroatrophic process

Deciphering the fibrotic process: mechanism of chronic radiation skin injury fibrosis

LncRNA-Dependent Mechanisms of Transforming Growth Factor-β: From Tissue Fibrosis to Cancer Progression

Signaling events required for TGF-β stimulation of CTGF expression and their role in fibrosis formation

Transforming growth factor alpha is a critical mediator of radiation lung injury

Pathogenetic mechanisms in radiation fibrosis

TGF-β Ligands, TGF-β Receptors, and Lung Cancer

Transforming Growth Factor-Β1-induced Epithelial-Mesenchymal Transition of Rat Type II Alveolar Epithelium and Pulmonary Fibrosis

Relationship Between Pulmonary Fibrosis and Transforming Growth Factor-Β/smad Signal Regulated by Cytokine

TGF-β signaling in health, disease, and therapeutics